Marker HCCR-1 protein highly expressed in colon cancer tissue and prognostic marker for colon cancer
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TIANJIN PEOPLE HOSPITAL
- Publication Date
- 2011-05-11
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biomedicine and relates to a marker protein highly expressed in colon cancer tissue and a colon cancer prognosis marker, wherein the marker includes HCCR-1 protein. Background technique
[0002] The morbidity and mortality of colorectal cancer in my country are increasing year by year. The key to improving the long-term survival rate of colorectal cancer is to accurately judge the prognosis and choose the appropriate treatment. The prognosis of colon cancer is closely related to factors such as Dukes stage, degree of differentiation, and tissue type. Tumor markers commonly used in the prognosis monitoring of colon cancer include ras, p53, bcl-2 genes, etc. The mutation or overexpression of these genes is of great significance to the judgment of the prognosis of patients and the selection of treatment options. However, because tumor metastasis involves many complex steps, it is still not accurate to use t...